Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 9/20 | 0.58 |
| ▸ | CDK5 | Q00535 | 9/20 | 0.58 |
| ▸ | CDK2 | P24941 | 8/20 | 0.58 |
| ▸ | CCNT1 | O60563 | 8/20 | 0.58 |
| ▸ | CDK5R1 | Q15078 | 8/20 | 0.58 |
| ▸ | CCNA2 | P20248 | 7/20 | 0.58 |
| ▸ | CCNA1 | P78396 | 7/20 | 0.58 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.50 |
| ▸ | CDC42BPB | Q9Y5S2 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.45 |
| ▸ | CDC7 | O00311 | 1/20 | 0.45 |
| ▸ | PLK4 | O00444 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.45 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.45 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.45 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.45 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1840300 | 0.85 | CDK9 (0.67) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL20758174 | 0.80 | CDK2 (0.52) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL20758175 | 0.79 | CDK2 (0.70) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL2239702 | 0.73 | CDK5 (1.00) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL24672940 | 0.73 | LRRK2 (0.48) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL1802877 | 0.73 | ROCK1 (0.46) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL24672937 | 0.73 | ROCK1 (0.57) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL20744107 | 0.73 | CDK9 (0.61) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL24672106 | 0.73 | CDK2 (0.61) | CDK9CDK5CDK2CCNT1CDK5R1 | |
| SCHEMBL30668694 | 0.73 | CDK9 (0.61) | CDK9CDK5CDK2CCNT1CDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11447505-B1 | Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2022-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11447505-B1 | Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer | PDXK, CCNK, CDC42BPB | CDK9 76/4885CDK5 257/4885CDK2 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.